Eli Lilly and Company (NYSE:LLY) announced a partnership with Rznomics to develop RNA-based gene therapies for sensorineural hearing loss, with milestone payments exceeding $1.3 billion.

Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...

Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...

Unlike the Get Better campaign — which was built throughout last year — Seeking launched with a full body of creative work, ...

His latest project is "Literally," a podcast in which the actor interviews notable celebrities like Maria Shriver, Chelsea ...

For us, halfway through the 2020s, it’s Mounjaro vs Ozempic, the battle of the fat jabs. In the first ever head-to-head ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

A world-leading experimental dementia drug designed to prevent the disease before it begins will be trialled in Australia for ...

NewLimit, an anti-aging biotech startup backed by Coinbase CEO Brian Armstrong, raised a $130 million Series B round.

Royal Melbourne Hospital (RMH) is one of more than a dozen sites around Australia taking part in the major global trial for ...

Graduation takes place at Memorial Stadium on Saturday night. Here are student-athletes from every sport who earned their ...

In fact, after finally graduating in law in her late forties, Shainwald, who has died just short of her 97th birthday, bested most of the men admitted in her stead in both longevity and impact, ...